Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial-Reference-Cited by-同舟云学术

Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial

Published:2023-04 Issue: Volume:178 Page:151-156
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lv Chao,Fang Wentao,Wu Nan,Jiao Wenjie,Xu Shidong,Ma Haitao,Wang Jia,Wang Rui,Ji Chunyu,Li Shaolei,Wang Yuzhao,Yan Shi,Lu Fangliang,Pei Yuquan,Liu Yinan,Yang Yue

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Cancer incidence and mortality in China, 2015;Zhang;J. Natl. Cancer Center,2021

3. The International association for the study of lung cancer lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer;Asamura;J. Thorac. Oncol.,2015

4. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data;NSCLC Meta-analysis Collaborative Group;Lancet,2014

5. Erlotinib as neoadjuvant therapy in stage IIIA (N2) mutation-positive non-small cell lung cancer: a prospective, single-arm, phase II study;Xiong;Oncologist,2019

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study;Journal of Clinical Oncology;2024-09-10

2. Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario;Current Oncology;2024-08-30

3. Early-Stage Non-Small Cell Lung Cancer: New Challenges with Immune Checkpoint Blockers and Targeted Therapies;Cancers;2024-08-06

4. Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer;Journal of Thoracic Oncology;2024-08

5. A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA–B GFPC 04-2020Study);Lung Cancer;2024-08